Reference
1. Messinis IE, Messini CI, Dafopoulos K. Novel aspects of the
endocrinology of the menstrual cycle. Reproductive biomedicine online.
2014 Jun;28(6):714-22.
2. Pelinck MJ, Hoek A, Simons AH,
Heineman MJ. Efficacy of natural cycle IVF: a review of the literature.
Human reproduction update. 2002 Mar-Apr;8(2):129-39.
3. Smacklon N, Fauser BC. Regulation
of follicle development and novel approaches to ovarian stimulation for
IVF. Human reproduction update. 2000 Jul-Aug;6(4):307-12.
4. Depalo R, Jayakrishan K, Garruti G,
Totaro I, Panzarino M, Giorgino F, et al. GnRH agonist versus GnRH
antagonist in in vitro fertilization and embryo transfer (IVF/ET).
Reproductive biology and endocrinology : RB&E. 2012 Apr 13;10:26.
5. Kumar P, Sharma A.
Gonadotropin-releasing hormone analogs: Understanding advantages and
limitations. Journal of Human Reproductive Sciences. 2014 July 1,
2014;7(3):170-4.
6. Tarlatzis BC, Fauser BC,
Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in
ovarian stimulation for IVF. Human reproduction update. 2006
Jul-Aug;12(4):333-40.
7. Al-Inany HG, Youssef MA, Ayeleke
RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone
antagonists for assisted reproductive technology. The Cochrane database
of systematic reviews. 2016 Apr 29;4:Cd001750.
8. Al-Inany HG, Youssef MA, Aboulghar
M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotrophin-releasing
hormone antagonists for assisted reproductive technology. The Cochrane
database of systematic reviews. 2011 May 11(5):Cd001750.
9. Kuang Y, Chen Q, Fu Y, Wang Y, Hong
Q, Lyu Q, et al. Medroxyprogesterone acetate is an effective oral
alternative for preventing premature luteinizing hormone surges in women
undergoing controlled ovarian hyperstimulation for in vitro
fertilization. Fertility and sterility. 2015 Jul;104(1):62-70.e3.
10. Wang Y, Chen Q, Wang N, Chen H,
Lyu Q, Kuang Y. Controlled Ovarian Stimulation Using Medroxyprogesterone
Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for
IVF: A Double-Blind Randomized Crossover Clinical Trial. Medicine. 2016
Mar;95(9):e2939.
11. Dong J, Wang Y, Chai WR, Hong QQ,
Wang NL, Sun LH, et al. The pregnancy outcome of progestin-primed
ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate
per day in infertile women undergoing in vitro fertilisation: a
randomised controlled trial. BJOG : an international journal of
obstetrics and gynaecology. 2017 Jun;124(7):1048-55.
12. Beguería R, García D, Vassena R,
Rodríguez A. Medroxyprogesterone acetate versus ganirelix in oocyte
donation: a randomized controlled trial. Human Reproduction.
2019;34(5):872-80.
13. Veeck LL. Oocyte assessment and
biological performance. Annals of the New York Academy of Sciences.
1988;541:259-74.
14. Lu X, Chen Q, Fu Y, Ai A, Lyu Q,
Kuang YP. Elevated progesterone on the trigger day does not impair the
outcome of Human Menotrophins Gonadotrophin and Medroxyprogesterone
acetate treatment cycles. Scientific reports. 2016 Aug 8;6:31112.
15. Requena A, Cruz M, Ruiz FJ,
Garcia-Velasco JA. Endocrine profile following stimulation with
recombinant follicle stimulating hormone and luteinizing hormone versus
highly purified human menopausal gonadotropin. Reproductive biology and
endocrinology : RB&E. 2014 Jan 29;12:10.
16. Vanni VS, Vigano P, Quaranta L,
Pagliardini L, Giardina P, Molgora M, et al. Are extremely high
progesterone levels still an issue in IVF? Journal of endocrinological
investigation. 2017 Jan;40(1):69-75.
17. Bu Z, Zhao F, Wang K, Guo Y, Su
Y, Zhai J, et al. Serum progesterone elevation adversely affects
cumulative live birth rate in different ovarian responders during in
vitro fertilization and embryo transfer: a large retrospective study.
PloS one. 2014;9(6):e100011.
18. Fair T, Lonergan P. The role of
progesterone in oocyte acquisition of developmental competence.
Reproduction in domestic animals = Zuchthygiene. 2012 Aug;47 Suppl
4:142-7.
19. O’Shea LC, Mehta J, Lonergan P,
Hensey C, Fair T. Developmental competence in oocytes and cumulus cells:
candidate genes and networks. Systems Biology in Reproductive Medicine.
2012 2012/04/01;58(2):88-101.
20. Urrego R, Herrera-Puerta E,
Chavarria NA, Camargo O, Wrenzycki C, Rodriguez-Osorio N. Follicular
progesterone concentrations and messenger RNA expression of MATER and
OCT-4 in immature bovine oocytes as predictors of developmental
competence. Theriogenology. 2015 Apr 15;83(7):1179-87.
21. Evans NP, Richter TA, Skinner DC,
Robinson JE. Neuroendocrine mechanisms underlying the effects of
progesterone on the oestradiol-induced GnRH/LH surge. Reproduction
(Cambridge, England) Supplement. 2002;59:57-66.
22. Heikinheimo O, Gordon K, Williams
RF, Hodgen GD. Inhibition of ovulation by progestin analogs (agonists vs
antagonists): Preliminary evidence for different sites and mechanisms of
actions. Contraception. 1996;53(1):55-64.
23. SOULES MR, STEINER RA, CLIFTON
DK, COHEN NL, AKSEL S, BREMNER WJ. Progesterone Modulation of Pulsatile
Luteinizing Hormone Secretion in Normal Women*. The Journal of Clinical
Endocrinology & Metabolism. 1984;58(2):378-83.
24. Chabbert-Buffeta N, Skinner DC,
Caraty A, Bouchard P. Neuroendocrine effects of progesterone. Steroids.
2000 2000/10/01/;65(10):613-20.
25. Mathieu d’Argent E, Ferrier C.
Outcomes of fertility preservation in women with endometriosis:
comparison of progestin-primed ovarian stimulation versus antagonist
protocols. 2020 Feb 13;13(1):18.
26. Massin N. New stimulation
regimens: endogenous and exogenous progesterone use to block the LH
surge during ovarian stimulation for IVF. Human reproduction update.
2017;23(2):211-20.
27. Evans MB, Parikh T, DeCherney AH,
Csokmay JM, Healy MW, Hill MJ. Evaluation of the cost-effectiveness of
ovulation suppression with progestins compared with GnRH analogs in
assisted reproduction cycles. Reproductive biomedicine online.
2019;38(5):691-8.
28. Yu S, Long H, Chang HY-n, Liu Y,
Gao H, Zhu J, et al. New application of dydrogesterone as a part of a
progestin-primed ovarian stimulation protocol for IVF: a randomized
controlled trial including 516 first IVF/ICSI cycles. Human
Reproduction. 2017;33(2):229-37.